David Hunter

David Hunter is Professor and Vice Chair of Ophthalmology at Harvard Medical School and Ophthalmologist-in-Chief at Boston Children's Hospital. He holds the Richard M. Robb Chair in Ophthalmology and leads the Children's Hospital Ophthalmology Foundation. His academic journey includes a BSc in Electrical Engineering from Rice University, followed by MD and PhD degrees in Cell Biology from Baylor College of Medicine.

• Rice University (BSc, 1979)
• Baylor College of Medicine (PhD, 1984)
• Baylor College of Medicine (MD, 1987)
• Massachusetts Eye and Ear Infirmary (Ophthalmology Residency, 1991)
• Johns Hopkins University (Pediatric Ophthalmology Fellowship, 1992)

Dr. Hunter's research focuses on strabismus and amblyopia, with collaborations in genetics (e.g., COL25A1 and TUBB3 mutations) and development of retinal birefringence scanning technology. He co-authored Learning Strabismus Surgery and Last-Minute Optics, and his work spans digital therapeutics, machine learning applications, and pediatric vision screening innovations like the Blinq device.

Recent publications highlight his expertise in genetic eye disorders (2025 studies on congenital cranial motor neuron disorders), health disparities in vision care (2025), and neuroimaging of amblyopia (2025). His work addresses surgical outcomes, telemedicine, and global pediatric ophthalmology access.

• Massachusetts' 12 Top Innovators (Boston Globe)
• Fellow of the American Academy of Ophthalmology
• Gold Fellow of ARVO
• Senior Fellow of IEEE
• Past Editor-in-Chief of the Journal of AAPOS
• Past Vice President of ARVO

Dr. Hunter co-founded Rebion, Inc., commercializing vision screening technology, and has driven growth of Boston Children's ophthalmology department to become the largest pediatric ophthalmology program globally. His clinical practice integrates adjustable suture techniques and superior rectus transposition for complex strabismus cases.